Literature DB >> 15309735

Adjustment of lipiodol dose according to tumor blood supply during transcatheter arterial chemoembolization for large hepatocellular carcinoma by multidetector helical CT.

Hong-Yan Cheng1, Yi Shou, Xiang Wang, Ai-Min Xu, Dong Chen, Yu-Chen Jia.   

Abstract

AIM: To work out an individualized lipiodol dose in transcatheter arterial chemoembolization (TACE) for large hepatocellular carcinoma (HCC) according to its blood supply evaluated by CT.
METHODS: One hundred patients with large HCC (more than 8 cm in diameter) were studied by multidetector helical CT. Patterns of blood supply of HCC were divided into sufficient blood supply, poor blood supply, mixed blood supply and arteriovenous (A-V) shunt. The dose of ultra-fluid lipiodol was determined by diameter and blood supply type of HCC. Patients were divided into two groups (50 cases each): lipiodol perfusion group and iodized oil perfusion group according to tumor diameter and the blood supply type of tumor.
RESULTS: The confirmation and effective rates were 82%, 84% in the first group and 36%, 46% in the second group (P<0.01).
CONCLUSION: A relatively individualized lipiodol dose may be determined according to the blood supply pattern and the tumor diameter by CT imaging.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309735      PMCID: PMC4572209          DOI: 10.3748/wjg.v10.i18.2753

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  5 in total

1.  Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center.

Authors:  T J Vogl; M Trapp; H Schroeder; M Mack; A Schuster; J Schmitt; P Neuhaus; R Felix
Journal:  Radiology       Date:  2000-02       Impact factor: 11.105

2.  Prognostic significance of arterial phase CT for prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: a retrospective analysis.

Authors:  S Katyal; J H Oliver; M S Peterson; P J Chang; R L Baron; B I Carr
Journal:  AJR Am J Roentgenol       Date:  2000-12       Impact factor: 3.959

3.  Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings.

Authors:  N Matsuo; H Uchida; H Sakaguchi; K Nishimine; Y Nishimura; S Hirohashi; H Ohishi
Journal:  Semin Oncol       Date:  1997-04       Impact factor: 4.929

4.  Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma.

Authors:  J W Chung; J H Park; J G Im; J K Han; M C Han
Journal:  Radiology       Date:  1993-06       Impact factor: 11.105

5.  Determination of the optimum dose level of lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis.

Authors:  N Nakao; H Uchida; K Kamino; Y Nishimura; H Ohishi; Y Takayasu; K Miura
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Mar-Apr       Impact factor: 2.740

  5 in total
  5 in total

Review 1.  Cerebral and pulmonary embolisms after transcatheter arterial chemoembolization for hepatocellular carcinoma.

Authors:  Chang Soo Choi; Ki Hoon Kim; Geom Seog Seo; Eun Young Cho; Hyo Jeong Oh; Suck Chei Choi; Tae Hyeon Kim; Haak Cheoul Kim; Byung Suk Roh
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

2.  Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carcinoma.

Authors:  Bao-Ming Luo; Yan-Ling Wen; Hai-Yun Yang; Hui Zhi; Xiao-Yun Xiao; Bing Ou; Jing-Sheng Pan; Jian-Hong Ma
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

3.  Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma.

Authors:  Eli Sapir; Yebin Tao; Matthew J Schipper; Latifa Bazzi; Paula M Novelli; Pauline Devlin; Dawn Owen; Kyle C Cuneo; Theodore S Lawrence; Neehar D Parikh; Mary Feng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-09-14       Impact factor: 7.038

Review 4.  Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?

Authors:  Eleni Liapi; Jean-Francois H Geschwind
Journal:  Cardiovasc Intervent Radiol       Date:  2010-11-12       Impact factor: 2.740

Review 5.  Liver embolizations in oncology: a review. Part I. Arterial (chemo)embolizations.

Authors:  Peter Gunvén
Journal:  Med Oncol       Date:  2007-08-03       Impact factor: 3.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.